CCL3L3 and COVID-19: In summary, FCGR3B is upregulated in a macrophage subtype (MoAM_CCL3L1) that is only observed in severe COVID-19 cases, hence differential regulation due to comorbidities or genetic mutations that impair FCGR3B are predicted to contribute to the severe course of COVID-19.